149 related articles for article (PubMed ID: 19715291)
1. Mutagenesis and evolution of sulfated antibodies using an expanded genetic code.
Liu CC; Choe H; Farzan M; Smider VV; Schultz PG
Biochemistry; 2009 Sep; 48(37):8891-8. PubMed ID: 19715291
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a Sulfated Anti-HIV Antibody Using an Expanded Genetic Code.
Li X; Hitomi J; Liu CC
Biochemistry; 2018 May; 57(20):2903-2907. PubMed ID: 29738662
[TBL] [Abstract][Full Text] [Related]
3. Protein evolution with an expanded genetic code.
Liu CC; Mack AV; Tsao ML; Mills JH; Lee HS; Choe H; Farzan M; Schultz PG; Smider VV
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17688-93. PubMed ID: 19004806
[TBL] [Abstract][Full Text] [Related]
4. Site-Specific Incorporation of Sulfotyrosine Using an Expanded Genetic Code.
Li X; Liu CC
Methods Mol Biol; 2018; 1728():191-200. PubMed ID: 29404999
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.
Huang CC; Venturi M; Majeed S; Moore MJ; Phogat S; Zhang MY; Dimitrov DS; Hendrickson WA; Robinson J; Sodroski J; Wyatt R; Choe H; Farzan M; Kwong PD
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2706-11. PubMed ID: 14981267
[TBL] [Abstract][Full Text] [Related]
6. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
[TBL] [Abstract][Full Text] [Related]
7. Efficient expression of tyrosine-sulfated proteins in E. coli using an expanded genetic code.
Liu CC; Cellitti SE; Geierstanger BH; Schultz PG
Nat Protoc; 2009; 4(12):1784-9. PubMed ID: 20010929
[TBL] [Abstract][Full Text] [Related]
8. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.
Choe H; Li W; Wright PL; Vasilieva N; Venturi M; Huang CC; Grundner C; Dorfman T; Zwick MB; Wang L; Rosenberg ES; Kwong PD; Burton DR; Robinson JE; Sodroski JG; Farzan M
Cell; 2003 Jul; 114(2):161-70. PubMed ID: 12887918
[TBL] [Abstract][Full Text] [Related]
10. Genetically encoded protein sulfation in mammalian cells.
Italia JS; Peeler JC; Hillenbrand CM; Latour C; Weerapana E; Chatterjee A
Nat Chem Biol; 2020 Apr; 16(4):379-382. PubMed ID: 32198493
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
Stone MJ; Payne RJ
Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
13. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
Neshat MN; Goodglick L; Lim K; Braun J
Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
[TBL] [Abstract][Full Text] [Related]
15. A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection.
Dorfman T; Moore MJ; Guth AC; Choe H; Farzan M
J Biol Chem; 2006 Sep; 281(39):28529-35. PubMed ID: 16849323
[TBL] [Abstract][Full Text] [Related]
16. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW
J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420
[TBL] [Abstract][Full Text] [Related]
17. Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome.
Neumann H; Wang K; Davis L; Garcia-Alai M; Chin JW
Nature; 2010 Mar; 464(7287):441-4. PubMed ID: 20154731
[TBL] [Abstract][Full Text] [Related]
18. Recombinant expression of selectively sulfated proteins in Escherichia coli.
Liu CC; Schultz PG
Nat Biotechnol; 2006 Nov; 24(11):1436-40. PubMed ID: 17072302
[TBL] [Abstract][Full Text] [Related]
19. An expanded genetic code with a functional quadruplet codon.
Anderson JC; Wu N; Santoro SW; Lakshman V; King DS; Schultz PG
Proc Natl Acad Sci U S A; 2004 May; 101(20):7566-71. PubMed ID: 15138302
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.
Seibert C; Cadene M; Sanfiz A; Chait BT; Sakmar TP
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11031-6. PubMed ID: 12169668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
